Jane Street’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Jane Street's GPCR Position: Q3 2026 in Review
Jane Street opened a new position in Structure Therapeutics (GPCR) in Q3 2026: 232,677 shares worth $7.28M. The stake represents ﹤0.01% of the portfolio and ranks #3207 among its holdings. This is a return to the name: Jane Street previously reported a position in GPCR as recently as Q4 2025.
Jane Street first reported a position in GPCR in Q4 2023 and has held it in 8 quarters since. The position peaked at $10.2M in Q4 2025. 172 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Jane Street held 232,677 shares of Structure Therapeutics worth $7.28M as of Q3 2026.
- Structure Therapeutics was a new Jane Street position in Q3 2026.
- Structure Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #3207 holding.
- Jane Street first reported a position in Structure Therapeutics in Q4 2023 and has held it in 8 quarters since.
- Jane Street's Structure Therapeutics position peaked at $10.2M in Q4 2025.
- 172 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.